Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

Articles published in
Brain
    April 2024
  1. LIMBERGER C, Zimmer ER
    Blood GFAP reflects astrocyte reactivity to Alzheimer's pathology in post-mortem brain tissue.
    Brain. 2024 Apr 18:awae104. doi: 10.1093.
    >> Share


  2. Correction to: Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia.
    Brain. 2024 Apr 10:awae103. doi: 10.1093.
    >> Share

  3. WANG YT, Therriault J, Servaes S, Tissot C, et al
    Sex-specific modulation of amyloid-beta on tau phosphorylation underlies faster tangle accumulation in females.
    Brain. 2024;147:1497-1510.
    >> Share

  4. TANAKA H, Martinez-Valbuena I, Forrest SL, Couto B, et al
    Distinct involvement of the cranial and spinal nerves in progressive supranuclear palsy.
    Brain. 2024;147:1399-1411.
    >> Share

  5. CORRIVEAU-LECAVALIER N, Barnard LR, Botha H, Graff-Radford J, et al
    Uncovering the distinct macro-scale anatomy of dysexecutive and behavioural degenerative diseases.
    Brain. 2024;147:1483-1496.
    >> Share

    March 2024
  6. HUNG C, Fertan E, Livesey FJ, Klenerman D, et al
    APP antisense oligonucleotides reduce Abeta aggregation and rescue endolysosomal dysfunction in Alzheimer's disease.
    Brain. 2024 Mar 25:awae092. doi: 10.1093.
    >> Share

  7. RODRIGUEZ-RODRIGUEZ P, Arroyo-Garcia LE, Tsagkogianni C, Li L, et al
    A cell autonomous regulator of neuronal excitability modulates tau in Alzheimer's disease vulnerable neurons.
    Brain. 2024 Mar 11:awae051. doi: 10.1093.
    >> Share

  8. RODRIGUEZ-VIEITEZ E, Vannini P, Montal V, Graff C, et al
    Cortical microstructural imaging from diffusion MRI: towards sensitive biomarkers for clinical trials.
    Brain. 2024;147:746-748.
    >> Share

  9. DE MEYER S, Blujdea ER, Schaeverbeke J, Reinartz M, et al
    Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes.
    Brain. 2024;147:936-948.
    >> Share

    February 2024
  10. YANG HS, Yau WW, Carlyle BC, Trombetta BA, et al
    Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.
    Brain. 2024 Feb 5:awae034. doi: 10.1093.
    >> Share

  11. AHMED H, Wang Y, Griffiths WJ, Levey AI, et al
    Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development.
    Brain. 2024 Feb 1:awae028. doi: 10.1093.
    >> Share

  12. ALBERT-GASCO H, Smith HL, Alvarez-Castelao B, Swinden D, et al
    Trazodone rescues dysregulated synaptic and mitochondrial nascent proteomes in prion neurodegeneration.
    Brain. 2024;147:649-664.
    >> Share

    January 2024
  13. KUMAR M, Quittot N, Dujardin S, Schlaffner CN, et al
    Alzheimer proteopathic tau seeds are biochemically a forme fruste of mature paired helical filaments.
    Brain. 2024 Jan 18:awad378. doi: 10.1093.
    >> Share

  14. KIIANITSA K, Lukes ME, Hayes BJ, Brutman J, et al
    TREM2 variants that cause early dementia and increase Alzheimer's disease risk affect gene splicing.
    Brain. 2024 Jan 16:awae014. doi: 10.1093.
    >> Share

  15. HAN Y, Chen K, Zhang B, Yu H, et al
    Maf1 loss regulates spinogenesis and attenuates cognitive impairment in Alzheimer's disease.
    Brain. 2024 Jan 16:awae015. doi: 10.1093.
    >> Share

  16. QIN C, Chen M, Dong MH, Yang S, et al
    Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders.
    Brain. 2024;147:163-176.
    >> Share

    December 2023
  17. SAMANTA S, Akhter F, Roy A, Chen D, et al
    New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer's disease.
    Brain. 2023 Dec 26:awad432. doi: 10.1093.
    >> Share

  18. SPOTORNO N, Strandberg O, Stomrud E, Janelidze S, et al
    Diffusion MRI tracks cortical microstructural changes during the early stages of Alzheimer's disease.
    Brain. 2023 Dec 21:awad428. doi: 10.1093.
    >> Share

  19. STOUFFER KM, Grande X, Duezel E, Johansson M, et al
    Amidst an amygdala renaissance in Alzheimer's disease.
    Brain. 2023 Dec 18:awad411. doi: 10.1093.
    >> Share

  20. YUYAMA K, Sun H, Fujii R, Hemmi I, et al
    Extracellular vesicle proteome unveils cathepsin B connection to Alzheimer's disease pathogenesis.
    Brain. 2023 Dec 10:awad361. doi: 10.1093.
    >> Share

  21. TARUTANI A, Kametani F, Tahira M, Saito Y, et al
    Distinct tau folds initiate templated seeding and alter the post-translational modification profile.
    Brain. 2023;146:4988-4999.
    >> Share

  22. GUBERT C, Hannan AJ
    Microbial manipulation of memories and minds.
    Brain. 2023;146:4791-4793.
    >> Share

    November 2023
  23. QUESNEL MJ, Labonte A, Picard C, Zetterberg H, et al
    Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains.
    Brain. 2023 Nov 22:awad398. doi: 10.1093.
    >> Share

  24. SILVA-RODRIGUEZ J, Labrador-Espinosa MA, Moscoso A, Scholl M, et al
    Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
    Brain. 2023;146:4520-4531.
    >> Share

  25. HAMPEL H, Elhage A, Cho M, Apostolova LG, et al
    Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics.
    Brain. 2023;146:4414-4424.
    >> Share

  26. RAMANAN VK, Gebre RK, Graff-Radford J, Hofrenning E, et al
    Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis.
    Brain. 2023;146:4508-4519.
    >> Share

    October 2023
  27. GRABRUCKER S, Marizzoni M, Silajdzic E, Lopizzo N, et al
    Microbiota from Alzheimer's patients induce deficits in cognition and hippocampal neurogenesis.
    Brain. 2023 Oct 18:awad303. doi: 10.1093.
    >> Share

  28. TUNOLD JA, Tan MMX, Koga S, Geut H, et al
    Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease.
    Brain. 2023;146:4077-4087.
    >> Share

  29. KEPP KP, Robakis NK, Hoilund-Carlsen PF, Sensi SL, et al
    The amyloid cascade hypothesis: an updated critical review.
    Brain. 2023;146:3969-3990.
    >> Share

  30. DU F, Yu Q, Swerdlow RH, Waites CL, et al
    Glucocorticoid-driven mitochondrial damage stimulates Tau pathology.
    Brain. 2023;146:4378-4394.
    >> Share

    September 2023
  31. COOMANS EM, van Westen D, Pichet Binette A, Strandberg O, et al
    Interactions between vascular burden and amyloid-beta pathology on trajectories of tau accumulation.
    Brain. 2023 Sep 18:awad317. doi: 10.1093.
    >> Share

  32. HARDY J, Mummery C
    Reply: Lecanemab: turning point, or status quo? An ethics perspective.
    Brain. 2023;146:e73.
    >> Share

  33. BOCANCEA DI, Svenningsson AL, van Loenhoud AC, Groot C, et al
    Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis.
    Brain. 2023;146:3719-3734.
    >> Share

  34. DALY T
    Lecanemab: turning point, or status quo? An ethics perspective.
    Brain. 2023;146:e71-e72.
    >> Share

  35. COOMANS EM, Tomassen J, Ossenkoppele R, Tijms BM, et al
    Genetically identical twin-pair difference models support the amyloid cascade hypothesis.
    Brain. 2023;146:3735-3746.
    >> Share

    August 2023
  36. KERAMIDIS I, McAllister BB, Bourbonnais J, Wang F, et al
    Restoring neuronal chloride extrusion reverses cognitive decline linked to Alzheimer's disease mutations.
    Brain. 2023 Aug 8:awad250. doi: 10.1093.
    >> Share

  37. JUNG Y, Damoiseaux JS
    The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease.
    Brain. 2023 Aug 4:awad267. doi: 10.1093.
    >> Share

  38. WUESTEFELD A, Pichet Binette A, Berron D, Spotorno N, et al
    Age-related and amyloid-beta-independent tau deposition and its downstream effects.
    Brain. 2023;146:3192-3205.
    >> Share

  39. RAHAYEL S, Tremblay C, Vo A, Misic B, et al
    Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies.
    Brain. 2023;146:3301-3318.
    >> Share

  40. MCMILLAN PJ, Benbow SJ, Uhrich R, Saxton A, et al
    Tau-RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change.
    Brain. 2023;146:3206-3220.
    >> Share

    July 2023
  41. GARCIA AM, de Leon J, Tee BL, Blasi DE, et al
    Speech and language markers of neurodegeneration: a call for global equity.
    Brain. 2023 Jul 27:awad253. doi: 10.1093.
    >> Share

  42. AKSMAN LM, Oxtoby NP, Scelsi MA, Wijeratne PA, et al
    A data-driven study of Alzheimer's disease related amyloid and tau pathology progression.
    Brain. 2023 Jul 11:awad232. doi: 10.1093.
    >> Share

  43. YOUNG AL, Vogel JW, Robinson JL, McMillan CT, et al
    Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
    Brain. 2023;146:2975-2988.
    >> Share

    June 2023

  44. Correction to: Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration.
    Brain. 2023 Jun 27:awad208. doi: 10.1093.
    >> Share

  45. VAN DER ENDE EL, In 't Veld SGJG, Hanskamp I, van der Lee S, et al
    CSF proteomics in autosomal dominant Alzheimer's disease highlights parallels with sporadic disease.
    Brain. 2023 Jun 22:awad213. doi: 10.1093.
    >> Share

  46. BANERJEE G, Collinge J, Fox NC, Lashley T, et al
    Clinical considerations in early-onset cerebral amyloid angiopathy.
    Brain. 2023 Jun 6:awad193. doi: 10.1093.
    >> Share

  47. SCHOONHOVEN DN, Coomans EM, Millan AP, van Nifterick AM, et al
    Tau protein spreads through functionally connected neurons in Alzheimer's disease: a combined MEG/PET study.
    Brain. 2023 Jun 5:awad189. doi: 10.1093.
    >> Share


  48. Correction: The most valuable player or the tombstone: is tau the correct target to treat Alzheimer's disease?
    Brain. 2023 Jun 1:awad176. doi: 10.1093.
    >> Share

  49. EDWARDS HM, Wallace CE, Gardiner WD, Doherty BM, et al
    Sex-dependent effects of acute stress on amyloid-beta in male and female mice.
    Brain. 2023;146:2268-2274.
    >> Share

  50. ROBINSON JL, Xie SX, Baer DR, Suh E, et al
    Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated.
    Brain. 2023;146:2557-2569.
    >> Share

    May 2023
  51. ZHU M, Xiao B, Xue T, Qin S, et al
    Cdc42GAP deficiency contributes to the Alzheimer's disease phenotype.
    Brain. 2023 May 31:awad184. doi: 10.1093.
    >> Share

  52. DAS V, Hajduch M
    Randomizing for Alzheimer's disease drug trials should consider the cancer history of participants.
    Brain. 2023 May 27:awad177. doi: 10.1093.
    >> Share

  53. HARDY J, Mummery C
    Reply: Unblinding in the lecanemab trial in Alzheimer's disease.
    Brain. 2023 May 23:awad201. doi: 10.1093.
    >> Share

  54. VAN GOOL WA
    Unblinding in the lecanemab trial in Alzheimer's disease.
    Brain. 2023 May 18:awad171. doi: 10.1093.
    >> Share

  55. KORETSKY MJ, Alvarado C, Makarious MB, Vitale D, et al
    Genetic risk factor clustering within and across neurodegenerative diseases.
    Brain. 2023 May 16:awad161. doi: 10.1093.
    >> Share

  56. JIANG J, Johnson JCS, Requena-Komuro MC, Benhamou E, et al
    Comprehension of acoustically degraded speech in Alzheimer's disease and primary progressive aphasia.
    Brain. 2023 May 15:awad163. doi: 10.1093.
    >> Share

  57. YOUNES K, Sha SJ
    The MVP or the tombstone: is tau the correct target to treat Alzheimer's disease?
    Brain. 2023 May 8:awad151. doi: 10.1093.
    >> Share

    April 2023
  58. GOSSYE H, Van Mossevelde S, Sieben A, Bjerke M, et al
    Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum.
    Brain. 2023;146:1624-1636.
    >> Share

  59. PONNUSAMY M, Wang S, Yuksel M, Hansen MT, et al
    Loss of forebrain BIN1 attenuates hippocampal pathology and neuroinflammation in a tauopathy model.
    Brain. 2023;146:1561-1579.
    >> Share

  60. NAM MH, Ko HY, Kim D, Lee S, et al
    Visualizing reactive astrocyte-neuron interaction in Alzheimer's disease using 11C-acetate and 18F-FDG.
    Brain. 2023 Apr 17:awad037. doi: 10.1093.
    >> Share

  61. MATTSSON-CARLGREN N, Palmqvist S
    The emerging era of staging Alzheimer's disease pathology using plasma biomarkers.
    Brain. 2023 Apr 6:awad112. doi: 10.1093.
    >> Share

    March 2023

  62. Correction to: Blood-brain barrier opening of the default mode network in Alzheimer's disease with magnetic resonance-guided focused ultrasound.
    Brain. 2023 Mar 22:awad082. doi: 10.1093.
    >> Share

  63. DONADIO V, Incensi A, Rizzo G, Westermark GT, et al
    Phosphorylated alpha-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy.
    Brain. 2023;146:1065-1074.
    >> Share

  64. GREVE HJ, Dunbar AL, Lombo CG, Ahmed C, et al
    The bidirectional lung brain-axis of amyloid-beta pathology: ozone dysregulates the peri-plaque microenvironment.
    Brain. 2023;146:991-1005.
    >> Share

    February 2023
  65. HARDY J, Mummery C
    An anti-amyloid therapy works for Alzheimer's disease: why has it taken so long and what is next?
    Brain. 2023 Feb 17:awad049. doi: 10.1093.
    >> Share

  66. JACK CR, Wiste HJ, Algeciras-Schimnich A, Figdore DJ, et al
    Predicting amyloid PET and tau PET stages with plasma biomarkers.
    Brain. 2023 Feb 15:awad042. doi: 10.1093.
    >> Share

  67. HUSAIN M
    Screening for Alzheimer's disease: plasma biomarkers and what else?
    Brain. 2023;146:407-408.
    >> Share

  68. FLORIAN H, Wang D, Arnold SE, Boada M, et al
    Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study.
    Brain. 2023 Feb 2:awad024. doi: 10.1093.
    >> Share

  69. KOCH G, Martorana A
    Reply: Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer disease?
    Brain. 2023 Feb 2:awad020. doi: 10.1093.
    >> Share

  70. D'AMELIO M, Di Lazzaro V
    Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer disease?
    Brain. 2023 Feb 2:awad019. doi: 10.1093.
    >> Share

    January 2023
  71. MARUSZAK A, Silajdzic E, Lee H, Murphy T, et al
    Predicting progression to Alzheimer's disease with human hippocampal progenitors exposed to serum.
    Brain. 2023 Jan 27:awac472. doi: 10.1093.
    >> Share

  72. MENG Y, Goubran M, Rabin JS, McSweeney M, et al
    Blood-brain barrier opening of the default mode network in Alzheimer's disease with magnetic resonance-guided focused ultrasound.
    Brain. 2023 Jan 25:awac459. doi: 10.1093.
    >> Share

  73. PERNECZKY R, Jessen F, Grimmer T, Levin J, et al
    Anti-amyloid antibody therapies in Alzheimer's disease.
    Brain. 2023 Jan 19:awad005. doi: 10.1093.
    >> Share

  74. JOHANSSON C, Thordardottir S, Laffita-Mesa J, Rodriguez-Vieitez E, et al
    Plasma biomarker profiles in autosomal dominant Alzheimer's disease.
    Brain. 2023 Jan 11:awac399. doi: 10.1093.
    >> Share

  75. WHEELOCK MD, Strain JF, Mansfield P, Tu JC, et al
    Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer's disease.
    Brain. 2023 Jan 10:awac498. doi: 10.1093.
    >> Share

  76. VAN ARENDONK J, Neitzel J, Steketee RME, van Assema DME, et al
    Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study.
    Brain. 2023;146:337-348.
    >> Share

  77. KATSUMI Y, Putcha D, Eckbo R, Wong B, et al
    Anterior dorsal attention network tau drives visual attention deficits in posterior cortical atrophy.
    Brain. 2023;146:295-306.
    >> Share

  78. BLOMMER J, Pitcher T, Mustapic M, Eren E, et al
    Extracellular vesicle biomarkers for cognitive impairment in Parkinson's disease.
    Brain. 2023;146:195-208.
    >> Share

    December 2022
  79. GONZALEZ-ORTIZ F, Turton M, Kac PR, Smirnov D, et al
    Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration.
    Brain. 2022 Dec 27:awac407. doi: 10.1093.
    >> Share

  80. KOOP EA, Jacobs HIL
    Untangling white matter fibre changes in Alzheimer's disease and small vessel disease.
    Brain. 2022 Dec 26:awac493. doi: 10.1093.
    >> Share

  81. WISCH JK, Butt OH, Gordon BA, Schindler SE, et al
    Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression.
    Brain. 2022 Dec 21:awac484. doi: 10.1093.
    >> Share

  82. PERANI D
    The impact of integrated brain molecular PET measures on DLB cognitive phenotype and clinical course.
    Brain. 2022;145:4157-4159.
    >> Share

    November 2022
  83. MOUSSAVI Z
    Repetitive TMS applied to the precuneus stabilizes cognitive status in Alzheimer's disease.
    Brain. 2022;145:3730-3732.
    >> Share

  84. OBERSTEIN TJ, Schmidt MA, Florvaag A, Haas AL, et al
    Amyloid-beta levels and cognitive trajectories in non-demented pTau181-positive subjects without amyloidopathy.
    Brain. 2022;145:4032-4041.
    >> Share

  85. BETTHAUSER TJ, Bilgel M, Koscik RL, Jedynak BM, et al
    Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts.
    Brain. 2022;145:4065-4079.
    >> Share

  86. HUGHES TM, Craft S
    Cerebral insulin receptors: a nexus for vascular and metabolic contributions to Alzheimer's disease.
    Brain. 2022 Nov 19:awac433. doi: 10.1093.
    >> Share

    October 2022
  87. SEYEDSALEHI A, Warrier V, Bethlehem RAI, Perry BI, et al
    Educational attainment, structural brain reserve and Alzheimer's disease: a Mendelian randomization analysis.
    Brain. 2022 Oct 31. pii: 6780317. doi: 10.1093.
    >> Share

  88. NEMY M, Dyrba M, Brosseron F, Buerger K, et al
    Cholinergic white matter pathways along the Alzheimer's disease continuum.
    Brain. 2022 Oct 26. pii: 6775152. doi: 10.1093.
    >> Share

  89. KOCH G, Casula EP, Bonni S, Borghi I, et al
    Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial.
    Brain. 2022 Oct 25. pii: 6701823. doi: 10.1093.
    >> Share

  90. LECLERC M, Bourassa P, Tremblay C, Caron V, et al
    Cerebrovascular insulin receptors are defective in Alzheimer's disease.
    Brain. 2022 Oct 25. pii: 6761474. doi: 10.1093.
    >> Share

  91. LI X, Ospitalieri S, Robberechts T, Hofmann L, et al
    Seeding, maturation and propagation of amyloid beta-peptide aggregates in Alzheimer's disease.
    Brain. 2022;145:3558-3570.
    >> Share

  92. SINGLETON EH, Fieldhouse JLP, van 't Hooft JJ, Scarioni M, et al
    Social cognition deficits and biometric signatures in the behavioural variant of Alzheimer's disease.
    Brain. 2022 Oct 21. pii: 6765142. doi: 10.1093.
    >> Share

    September 2022
  93. SPOTORNO N, Strandberg O, Vis G, Stomrud E, et al
    Measures of cortical microstructure are linked to amyloid pathology in Alzheimer's disease.
    Brain. 2022 Sep 21. pii: 6710203. doi: 10.1093.
    >> Share

  94. JANELIDZE S, Bali D, Ashton NJ, Barthelemy NR, et al
    Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.
    Brain. 2022 Sep 10. pii: 6695388. doi: 10.1093.
    >> Share

  95. GROOT C, Smith R, Stomrud E, Binette AP, et al
    Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals.
    Brain. 2022 Sep 9. pii: 6695020. doi: 10.1093.
    >> Share

  96. BUCKLEY R
    Sex differences in Alzheimer's disease risk: are immune responses the key?
    Brain. 2022 Sep 2. pii: 6686583. doi: 10.1093.
    >> Share

    August 2022
  97. RABIN JS, Nichols E, La Joie R, Casaletto KB, et al
    Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline.
    Brain. 2022;145:2823-2833.
    >> Share

  98. SNELLMAN A, Lantero-Rodriguez J, Emersic A, Vrillon A, et al
    N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases.
    Brain. 2022;145:2834-2848.
    >> Share

  99. RIKU Y, Iwasaki Y, Ishigaki S, Akagi A, et al
    Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Brain. 2022;145:2769-2784.
    >> Share

  100. SAPKOTA D, Florian C, Doherty BM, White KM, et al
    Aqp4 stop codon readthrough facilitates amyloid-beta clearance from the brain.
    Brain. 2022 Aug 24. pii: 6671408. doi: 10.1093.
    >> Share

  101. INSEL PS, Young CB, Aisen PS, Johnson KA, et al
    Tau positron emission tomography in preclinical Alzheimer's disease.
    Brain. 2022 Aug 13. pii: 6665667. doi: 10.1093.
    >> Share

  102. COURSE MM, Gudsnuk K, Keene CD, Bird TD, et al
    Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer's disease.
    Brain. 2022 Aug 11. pii: 6660735. doi: 10.1093.
    >> Share

  103. LUO J, Agboola F, Grant E, Morris JC, et al
    Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan.
    Brain. 2022 Aug 4. pii: 6655799. doi: 10.1093.
    >> Share

    July 2022
  104. HUSAIN M
    Molecular pathology and biomarker of progression in Alzheimer's disease.
    Brain. 2022;145:2229-2230.
    >> Share

  105. GROOT C, Holstege H, Ossenkoppele R
    Do genetic factors contribute to sex-specific differences in resilience to amyloid pathology?
    Brain. 2022;145:2239-2241.
    >> Share

  106. CASALETTO KB, Nichols E, Aslanyan V, Simone SM, et al
    Sex-specific effects of microglial activation on Alzheimer's disease proteinopathy in older adults.
    Brain. 2022 Jul 23. pii: 6648895. doi: 10.1093.
    >> Share

  107. LONG JM, Coble DW, Xiong C, Schindler SE, et al
    Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes.
    Brain. 2022 Jul 22. pii: 6648721. doi: 10.1093.
    >> Share

  108. DEWENTER A, Jacob MA, Cai M, Gesierich B, et al
    Disentangling the effects of Alzheimer's and small vessel disease on white matter fibre tracts.
    Brain. 2022 Jul 21. pii: 6647593. doi: 10.1093.
    >> Share

  109. BIESSELS GJ
    Alzheimer's disease, cerebrovascular disease and dementia: lump, split or integrate?
    Brain. 2022 Jul 15. pii: 6644842. doi: 10.1093.
    >> Share

  110. WANG Q, Huang X, Su Y, Yin G, et al
    Activation of Wnt/beta-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease.
    Brain. 2022 Jul 5. pii: 6630034. doi: 10.1093.
    >> Share

    June 2022
  111. GRAHAM NSN
    Progress towards predicting neurodegeneration and dementia after traumatic brain injury.
    Brain. 2022;145:1874-1876.
    >> Share

  112. JENKINS LM, Wang L, Rosen H, Weintraub S, et al
    A transdiagnostic review of neuroimaging studies of apathy and disinhibition in dementia.
    Brain. 2022;145:1886-1905.
    >> Share

  113. MEHRARAM R, Peraza LR, Murphy NRE, Cromarty RA, et al
    Functional and structural brain network correlates of visual hallucinations in Lewy body dementia.
    Brain. 2022;145:2190-2205.
    >> Share

  114. LEVEY AI, Qiu D, Zhao L, Hu WT, et al
    A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment.
    Brain. 2022;145:1924-1938.
    >> Share

  115. TANNER JA, Iaccarino L, Edwards L, Asken BM, et al
    Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease.
    Brain. 2022 Jun 28. pii: 6619120. doi: 10.1093.
    >> Share

  116. KAIVOLA K, Shah Z, Chia R, Scholz SW, et al
    Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups.
    Brain. 2022;145:1757-1762.
    >> Share

    May 2022
  117. TONIOLO S
    What plasma biomarkers tell us about hippocampal microstructural changes in Alzheimer's disease.
    Brain. 2022 May 25. pii: 6591892. doi: 10.1093.
    >> Share

  118. DUZEL E, Ziegler G, Berron D, Maass A, et al
    Amyloid pathology but not APOE epsilon4 status is permissive for tau-related hippocampal dysfunction.
    Brain. 2022;145:1473-1485.
    >> Share

  119. KO H, Kim S, Kim K, Jung SH, et al
    Genome-wide association study of occupational attainment as a proxy for cognitive reserve.
    Brain. 2022;145:1436-1448.
    >> Share

  120. MORRIS JC, Weiner M, Xiong C, Beckett L, et al
    Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology.
    Brain. 2022 May 17. pii: 6587090. doi: 10.1093.
    >> Share

  121. MORRISON MS, Aparicio HJ, Blennow K, Zetterberg H, et al
    Antemortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy.
    Brain. 2022 May 13. pii: 6585495. doi: 10.1093.
    >> Share


  122. Correction to: Brain amyloid-beta oligomers in ageing and Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585189. doi: 10.1093.
    >> Share

  123. EISSMAN JM, Dumitrescu L, Mahoney ER, Smith AN, et al
    Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585174. doi: 10.1093.
    >> Share

  124. ZHU WM, Neuhaus A, Beard DJ, Sutherland BA, et al
    Neurovascular coupling mechanisms in health and neurovascular uncoupling in Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585171. doi: 10.1093.
    >> Share

  125. VROMEN EM, de Boer SCM, Teunissen CE, Rozemuller A, et al
    Biomarker A+T-: is this Alzheimer's disease or not? A combined CSF and pathology study.
    Brain. 2022 May 2. pii: 6576655. doi: 10.1093.
    >> Share

    April 2022
  126. BARKER MS, Gottesman RT, Manoochehri M, Chapman S, et al
    Proposed research criteria for prodromal behavioural variant frontotemporal dementia.
    Brain. 2022;145:1079-1097.
    >> Share

  127. LEGAZ A, Abrevaya S, Dottori M, Gonzalez Campo C, et al
    Multimodal mechanisms of human socially reinforced learning across neurodegenerative diseases.
    Brain. 2022;145:1052-1068.
    >> Share

  128. MESULAM MM, Coventry CA, Bigio EH, Sridhar J, et al
    Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia.
    Brain. 2022 Apr 20. pii: 6570516. doi: 10.1093.
    >> Share

  129. SHAHID SS, Wen Q, Risacher SL, Farlow MR, et al
    Hippocampal-subfield microstructures and their relation to plasma biomarkers in Alzheimer's disease.
    Brain. 2022 Apr 12. pii: 6566798. doi: 10.1093.
    >> Share

  130. OLIVEROS G, Wallace CH, Chaudry O, Liu Q, et al
    Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation.
    Brain. 2022 Apr 12. pii: 6566790. doi: 10.1093.
    >> Share

  131. STEVENSON-HOARE J, Heslegrave A, Leonenko G, Fathalla D, et al
    Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease.
    Brain. 2022 Apr 6. pii: 6564132. doi: 10.1093.
    >> Share

  132. PADHI S, Sarangi S, Nayak N, Pati A, et al
    OAS1 rs1131454 genetic variant is associated with Alzheimer's disease: an epidemiological analysis.
    Brain. 2022 Apr 6. pii: 6564066. doi: 10.1093.
    >> Share

    March 2022
  133. JEONG YY, Han S, Jia N, Zhang M, et al
    Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy.
    Brain. 2022;145:305-323.
    >> Share

  134. BENATAR M, Wuu J, McHutchison C, Postuma RB, et al
    Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
    Brain. 2022;145:27-44.
    >> Share

  135. HOSOKAWA M, Masuda-Suzukake M, Shitara H, Shimozawa A, et al
    Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms.
    Brain. 2022;145:349-361.
    >> Share

  136. GIACOBINI E, Cuello AC, Fisher A
    Reimagining cholinergic therapy for Alzheimer's disease.
    Brain. 2022 Mar 15. pii: 6548684. doi: 10.1093.
    >> Share

  137. SHETTY AK
    Can rapamycin slow down memory decline in Alzheimer's disease with seizures?
    Brain. 2022 Mar 12. pii: 6547363. doi: 10.1093.
    >> Share

  138. LAM AD, Shafi MM
    Towards a coherent view of network hyperexcitability in Alzheimer's disease.
    Brain. 2022 Mar 8. pii: 6544859. doi: 10.1093.
    >> Share

  139. LIN CP, Frigerio I, Boon BDC, Zhou Z, et al
    Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease.
    Brain. 2022 Mar 8. pii: 6543231. doi: 10.1093.
    >> Share

  140. GABRIELLI M, Prada I, Joshi P, Falcicchia C, et al
    Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer's disease.
    Brain. 2022 Mar 3. pii: 6541881. doi: 10.1093.
    >> Share

    February 2022
  141. BEAMAN EE, Bonde AN, Ulv Larsen SM, Ozenne B, et al
    Blood-brain barrier permeable beta-blockers linked to lower risk of Alzheimer's disease in hypertension.
    Brain. 2022 Feb 23. pii: 6535129. doi: 10.1093.
    >> Share

  142. PERIS L, Parato J, Qu X, Soleilhac JM, et al
    Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer's disease.
    Brain. 2022 Feb 11. pii: 6527175. doi: 10.1093.
    >> Share

    January 2022
  143. KARANTH SD, Katsumata Y, Nelson PT, Fardo DW, et al
    Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer's-type neuropathology.
    Brain. 2022 Jan 30. pii: 6517521. doi: 10.1093.
    >> Share

  144. WIESMAN AI, Murman DL, Losh RA, Schantell M, et al
    Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer's disease.
    Brain. 2022 Jan 28. pii: 6516524. doi: 10.1093.
    >> Share

  145. MARTINO ADAMI PV, Orellana A, Garcia P, Kleineidam L, et al
    Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type.
    Brain. 2022 Jan 28. pii: 6516341. doi: 10.1093.
    >> Share

  146. STERN AM, Liu L, Jin S, Liu W, et al
    A calcium-sensitive antibody isolates soluble amyloid-beta aggregates and fibrils from Alzheimer's disease brain.
    Brain. 2022 Jan 27. pii: 6516009. doi: 10.1093.
    >> Share

  147. ALI M, Falkenhain K, Njiru BN, Murtaza-Ali M, et al
    VEGF signalling causes stalls in brain capillaries and reduces cerebral blood flow in Alzheimer's mice.
    Brain. 2022 Jan 20. pii: 6512043. doi: 10.1093.
    >> Share

  148. BRIDEL C, Somers C, Sieben A, Rozemuller A, et al
    Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers.
    Brain. 2022 Jan 13. pii: 6506576. doi: 10.1093.
    >> Share

  149. COOMANS EM, Tomassen J, Ossenkoppele R, Golla SSV, et al
    Genetically identical twins show comparable tau PET load and spatial distribution.
    Brain. 2022 Jan 12. pii: 6504924. doi: 10.1093.
    >> Share

    December 2021
  150. LEE Y, Miller MR, Fernandez MA, Berg EL, et al
    Early lysosome defects precede neurodegeneration with amyloid-beta and tau aggregation in NHE6-null rat brain.
    Brain. 2021 Dec 20. pii: 6470622. doi: 10.1093.
    >> Share

  151. RANASINGHE KG, Kudo K, Hinkley L, Beagle A, et al
    Neuronal synchrony abnormalities associated with subclinical epileptiform activity in early onset Alzheimer's disease.
    Brain. 2021 Dec 17. pii: 6469013. doi: 10.1093.
    >> Share

  152. XHIMA K, Markham-Coultes K, Kofoed RH, Saragovi HU, et al
    Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies.
    Brain. 2021 Dec 17. pii: 6469023. doi: 10.1093.
    >> Share

  153. TSAI HH, Chen YF, Yen RF, Lo YL, et al
    Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau.
    Brain. 2021;144:3371-3380.
    >> Share

  154. PASCOAL TA, Benedet AL, Tudorascu DL, Therriault J, et al
    Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
    Brain. 2021;144:3517-3528.
    >> Share

  155. ABRAHAMSON EE, Kofler JK, Becker CR, Price JC, et al
    11C-PiB PET can underestimate brain amyloid-beta burden when cotton wool plaques are numerous.
    Brain. 2021 Dec 16. pii: 6464340. doi: 10.1093.
    >> Share

    November 2021
  156. VERDI S, Marquand AF, Schott JM, Cole JH, et al
    Beyond the average patient: how neuroimaging models can address heterogeneity in dementia.
    Brain. 2021;144:2946-2953.
    >> Share

    October 2021
  157. ZHANG Y, Zhang Y, Aman Y, Ng CT, et al
    Amyloid-beta toxicity modulates tau phosphorylation through the PAX6 signalling pathway.
    Brain. 2021;144:2759-2770.
    >> Share

  158. LUCEY BP, Wisch J, Boerwinkle AH, Landsness EC, et al
    Sleep and longitudinal cognitive performance in preclinical and early symptomatic Alzheimer's disease.
    Brain. 2021 Oct 20. pii: 6401973. doi: 10.1093.
    >> Share

  159. LEVY JP, Bezgin G, Savard M, Pascoal TA, et al
    18F-MK-6240 tau-PET in genetic frontotemporal dementia.
    Brain. 2021 Oct 19. pii: 6402002. doi: 10.1093.
    >> Share

  160. MAGUSALI N, Graham AC, Piers TM, Panichnantakul P, et al
    A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene.
    Brain. 2021 Oct 7. pii: 6382473. doi: 10.1093.
    >> Share

  161. KHAN AF, Adewale Q, Baumeister TR, Carbonell F, et al
    Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease.
    Brain. 2021 Oct 4. pii: 6380944. doi: 10.1093.
    >> Share

  162. SCHUMACHER J, Ray NJ, Hamilton CA, Donaghy PC, et al
    Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease.
    Brain. 2021 Oct 4. pii: 6380941. doi: 10.1093.
    >> Share

    September 2021

  163. Erratum to: Cardiovascular brain impulses in Alzheimer's disease.
    Brain. 2021 Sep 22. pii: 6373794. doi: 10.1093.
    >> Share

  164. STOTHART G, Smith LJ, Milton A, Coulthard E, et al
    A passive and objective measure of recognition memory in Alzheimer's disease using Fastball memory assessment.
    Brain. 2021 Sep 20. pii: 6372384. doi: 10.1093.
    >> Share

    August 2021
  165. KHAN AR, Ottoy J, Goubran M
    Towards a comprehensive 3D mapping of tau progression in early Alzheimer's disease.
    Brain. 2021 Aug 23. pii: 6356553. doi: 10.1093.
    >> Share

  166. DAVILA-BOUZIGUET E, Casoliba-Melich A, Targa-Fabra G, Galera-Lopez L, et al
    Functional protection in J20/VLW mice: a model of non-demented with Alzheimer's disease neuropathology.
    Brain. 2021 Aug 23. pii: 6356505. doi: 10.1093.
    >> Share

  167. BOYLE PA, Wang T, Yu L, Wilson RS, et al
    To what degree is late life cognitive decline driven by age-related neuropathologies?
    Brain. 2021;144:2166-2175.
    >> Share

  168. HOLLAND N, Malpetti M, Rittman T, Mak EE, et al
    Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.
    Brain. 2021 Aug 16. pii: 6353021. doi: 10.1093.
    >> Share

  169. STROM A, Iaccarino L, Edwards L, Lesman-Segev OH, et al
    Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
    Brain. 2021 Aug 9. pii: 6346980. doi: 10.1093.
    >> Share

    July 2021
  170. PAUMIER A, Boisseau S, Jacquier-Sarlin M, Pernet-Gallay K, et al
    Astrocyte-neuron interplay is critical for Alzheimer's disease pathogenesis and is rescued by TRPA1 channel blockade.
    Brain. 2021 Jul 24. pii: 6327685. doi: 10.1093.
    >> Share

  171. GOURMAUD S, Stewart DA, Irwin DJ, Roberts N, et al
    The role of mTORC1 activation in seizure-induced exacerbation of Alzheimer's disease.
    Brain. 2021 Jul 15. pii: 6321945. doi: 10.1093.
    >> Share

  172. BERRON D, van Westen D, Ossenkoppele R, Strandberg O, et al
    Corrigendum to: Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease.
    Brain. 2021 Jul 14. pii: 6321152. doi: 10.1093.
    >> Share

  173. PEREIRA JB, Janelidze S, Smith R, Mattsson-Carlgren N, et al
    Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer's disease.
    Brain. 2021 Jul 14. pii: 6321226. doi: 10.1093.
    >> Share

  174. BAILES SM, Lewis LD
    Distinct cardiac-locked brain pulsations in Alzheimer's disease.
    Brain. 2021 Jul 9. pii: 6318392. doi: 10.1093.
    >> Share

  175. HORIE K, Barthelemy NR, Sato C, Bateman RJ, et al
    Corrigendum to: CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease.
    Brain. 2021 Jul 3. pii: 6313379. doi: 10.1093.
    >> Share

    June 2021
  176. RIES M, Watts H, Mota BC, Lopez MY, et al
    Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-beta and tau pathology.
    Brain. 2021;144:1526-1541.
    >> Share

  177. MATTHEWS DC, Mao X, Dowd K, Tsakanikas D, et al
    Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.
    Brain. 2021 Jun 18. pii: 6305835. doi: 10.1093.
    >> Share

  178. PATEL AG, Nehete PN, Krivoshik SR, Pei X, et al
    Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys.
    Brain. 2021 Jun 15. pii: 6297373. doi: 10.1093.
    >> Share

  179. SCHUMACHER J, Gunter JL, Przybelski SA, Jones DT, et al
    Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
    Brain. 2021 Jun 11. pii: 6296589. doi: 10.1093.
    >> Share

    May 2021

  180. Erratum to: The development and convergence of co-pathologies in Alzheimer's disease.
    Brain. 2021 May 23. pii: 6282423. doi: 10.1093.
    >> Share

  181. DEHGHANI N, Bras J, Guerreiro R
    Erratum to: How understudied populations have contributed to our understanding of Alzheimer's disease genetics.
    Brain. 2021 May 20. pii: 6279241. doi: 10.1093.
    >> Share

    April 2021
  182. O'CONNOR A, Pannee J, Poole T, Arber C, et al
    Plasma amyloid-beta ratios in autosomal dominant Alzheimer's disease: the influence of genotype.
    Brain. 2021 Apr 23. pii: 6248083. doi: 10.1093.
    >> Share

  183. DEHGHANI N, Bras J, Guerreiro R
    How understudied populations have contributed to our understanding of Alzheimer's disease genetics.
    Brain. 2021 Apr 23. pii: 6247156. doi: 10.1093.
    >> Share

  184. YAO Y, Kang SS, Xia Y, Wang ZH, et al
    A delta-secretase-truncated APP fragment activates CEBPB, mediating Alzheimer's disease pathologies.
    Brain. 2021 Apr 20. pii: 6242262. doi: 10.1093.
    >> Share


  185. Erratum to: Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Brain. 2021 Apr 20. pii: 6238673. doi: 10.1093.
    >> Share

  186. OZAWA S, Hori Y, Shimizu Y, Taniguchi A, et al
    Photo-oxygenation by a biocompatible catalyst reduces amyloid-beta levels in Alzheimer's disease mice.
    Brain. 2021 Apr 14. pii: 6224831. doi: 10.1093.
    >> Share

  187. TOME SO, Thal DR
    Co-pathologies in Alzheimer's disease: just multiple pathologies or partners in crime?
    Brain. 2021;144:706-708.
    >> Share


  188. Corrigendum to: Monitoring the progression of Alzheimer's disease with tau-PET.
    Brain. 2021 Apr 6. pii: 6213355. doi: 10.1093.
    >> Share

    March 2021
  189. RAJNA Z, Mattila H, Huotari N, Tuovinen T, et al
    Cardiovascular brain impulses in Alzheimer's disease.
    Brain. 2021 Mar 31. pii: 6206368. doi: 10.1093.
    >> Share

  190. YAP SY, Frias B, Wren MC, Scholl M, et al
    Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease.
    Brain. 2021 Mar 20. pii: 6179104. doi: 10.1093.
    >> Share

  191. EWERS M, Luan Y, Frontzkowski L, Neitzel J, et al
    Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease.
    Brain. 2021 Mar 16. pii: 6174116. doi: 10.1093.
    >> Share

  192. ASBY D, Boche D, Allan S, Love S, et al
    Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease.
    Brain. 2021 Mar 16. pii: 6173392. doi: 10.1093.
    >> Share

  193. SPINA S, La Joie R, Petersen C, Nolan AL, et al
    Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease.
    Brain. 2021 Mar 9. pii: 6164966. doi: 10.1093.
    >> Share

  194. HUSAIN M
    Blood tests to screen for Alzheimer's disease.
    Brain. 2021;144:355-356.
    >> Share

  195. KIM JH, Afridi R, Han J, Jung HG, et al
    Gamma subunit of complement component 8 is a neuroinflammation inhibitor.
    Brain. 2021;144:528-552.
    >> Share

    February 2021
  196. JAGUST W
    Integrating events in the disintegration of Alzheimer's disease.
    Brain. 2021;144:11-14.
    >> Share

  197. TIJMS BM, Teunissen CE
    Concatenating plasma p-tau to Alzheimer's disease.
    Brain. 2021;144:14-17.
    >> Share

    January 2021
  198. KESHAVAN A, Pannee J, Karikari TK, Rodriguez JL, et al
    Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70.
    Brain. 2021 Jan 22. pii: 6105867. doi: 10.1093.
    >> Share


  199. Erratum to: Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
    Brain. 2021 Jan 12. pii: 6091150. doi: 10.1093.
    >> Share

    December 2020
  200. JOHNSON JCS, Marshall CR, Weil RS, Bamiou DE, et al
    Hearing and dementia: from ears to brain.
    Brain. 2020 Dec 22. pii: 6044086. doi: 10.1093.
    >> Share

  201. MONTERO-CRESPO M, Dominguez-Alvaro M, Alonso-Nanclares L, DeFelipe J, et al
    Three-dimensional analysis of synaptic organization in the hippocampal CA1 field in Alzheimer's disease.
    Brain. 2020 Dec 16. pii: 6038920. doi: 10.1093.
    >> Share

  202. HORIE K, Barthelemy NR, Sato C, Bateman RJ, et al
    CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease.
    Brain. 2020 Dec 7. pii: 6024973. doi: 10.1093.
    >> Share

  203. TEUNISSEN CE, Thijssen EH, Verberk IMW
    Plasma p-tau217: from 'new kid' to most promising candidate for Alzheimer's disease blood test.
    Brain. 2020;143:3170-3172.
    >> Share

  204. PEREIRA JB, Janelidze S, Ossenkoppele R, Kvartsberg H, et al
    Untangling the association of amyloid-beta and tau with synaptic and axonal loss in Alzheimer's disease.
    Brain. 2020 Dec 5. pii: 6024803. doi: 10.1093.
    >> Share

  205. TIJMS BM, Gobom J, Reus L, Jansen I, et al
    Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
    Brain. 2020;143:3776-3792.
    >> Share

  206. SMITH R, Strandberg O, Mattsson-Carlgren N, Leuzy A, et al
    The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
    Brain. 2020;143:3805-3815.
    >> Share

  207. FLORES-AGUILAR L, Iulita MF, Kovecses O, Torres MD, et al
    Evolution of neuroinflammation across the lifespan of individuals with Down syndrome.
    Brain. 2020;143:3653-3671.
    >> Share

    November 2020
  208. MOSCOSO A, Grothe MJ, Ashton NJ, Karikari TK, et al
    Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Brain. 2020 Nov 30. pii: 6012955. doi: 10.1093.
    >> Share

  209. BRIER MR, Day GS
    Serum neurofilament light chain uncovers neurodegeneration early in the course of Alzheimer's disease.
    Brain. 2020 Nov 30. pii: 6012788. doi: 10.1093.
    >> Share

  210. SUR C, Kost J, Scott D, Adamczuk K, et al
    BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
    Brain. 2020 Nov 30. pii: 6012787. doi: 10.1093.
    >> Share

  211. RUAN Z, Pathak D, Venkatesan Kalavai S, Yoshii-Kitahara A, et al
    Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
    Brain. 2020 Nov 27. pii: 6007752. doi: 10.1093.
    >> Share

  212. BENEDET AL, Leuzy A, Pascoal TA, Ashton NJ, et al
    Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Brain. 2020 Nov 19. pii: 5990278. doi: 10.1093.
    >> Share

  213. JIA L, Li F, Wei C, Zhu M, et al
    Prediction of Alzheimer's disease using multi-variants from a Chinese genome-wide association study.
    Brain. 2020 Nov 14. pii: 5981992. doi: 10.1093.
    >> Share

  214. LIU KY, Reeves S, McAleese KE, Attems J, et al
    Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's disease.
    Brain. 2020 Nov 14. pii: 5981742. doi: 10.1093.
    >> Share

  215. JI X, Liu G
    rs34331204 regulates TSPAN13 expression and contributes to Alzheimer's disease with sex differences.
    Brain. 2020 Nov 11. pii: 5974904. doi: 10.1093.
    >> Share

  216. DUMITRESCU L, Hohman TJ
    Reply: rs34331204 regulates TSPAN13 expression and contributes to Alzheimer's disease with sex differences.
    Brain. 2020 Nov 11. pii: 5974883. doi: 10.1093.
    >> Share

  217. JOSEPHS KA, Martin PR, Weigand SD, Tosakulwong N, et al
    Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
    Brain. 2020 Nov 5. pii: 5956321. doi: 10.1093.
    >> Share

  218. SOLEIMANI-MEIGOONI DN, Iaccarino L, La Joie R, Baker S, et al
    18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
    Brain. 2020 Nov 3. pii: 5952719. doi: 10.1093.
    >> Share

    October 2020
  219. MATTSSON-CARLGREN N, Janelidze S, Palmqvist S, Cullen N, et al
    Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease.
    Brain. 2020 Oct 17. pii: 5929275. doi: 10.1093.
    >> Share

    September 2020
  220. HARDY CJD, Yong KXX, Goll JC, Crutch SJ, et al
    Impairments of auditory scene analysis in posterior cortical atrophy.
    Brain. 2020 Sep 1. pii: 5900355. doi: 10.1093.
    >> Share

    July 2020
  221. PASCOAL TA, Therriault J, Benedet AL, Savard M, et al
    18F-MK-6240 PET for early and late detection of neurofibrillary tangles.
    Brain. 2020 Jul 16. pii: 5872095. doi: 10.1093.
    >> Share

    June 2020
  222. PRZYBYLA M, van Eersel J, van Hummel A, van der Hoven J, et al
    Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signature.
    Brain. 2020;143:1889-1904.
    >> Share

    January 2020
  223. ROBINSON JL, Richardson H, Xie SX, Suh E, et al
    The development and convergence of co-pathologies in Alzheimer's disease.
    Brain. 2020 Jan 15. pii: 6101614. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016